REFRACTORY ANAEMIA side effect
What is REFRACTORY ANAEMIA ?Drugs associated with REFRACTORY ANAEMIA
ARANESP CARBOPLATIN CYCLOPHOSPHAMIDE EXJADE GEMZAR HYDROXYCHLOROQUI PLAVIX PROCRIT RITUXIMAB THALOMIDREFRACTORY ANAEMIA : Procrit Side Effects Report #5689496-5
Physician from UNITED STATES reported PROCRIT problem on Mar 19, 2008. Female patient was diagnosed with dialysis and was treated with PROCRIT. After drug was administered, patient experienced the following problems/side effects: refractory anaemia, . PROCRIT dosage: unknown. Patient recovered.
REFRACTORY ANAEMIA : Rituximab Side Effects Report #5639373-0
RITUXIMAB problem was reported by a Physician from FRANCE on Feb 18, 2008. Female patient, weighting 154.3 lb, was diagnosed with b-cell lymphoma, prophylaxis, hypertension, osteoporosis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: refractory anaemia, . RITUXIMAB dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, ZECLAR, TRIFLUCAN, TENSTATEN, FOSAMAX. Patient was hospitalized. Patient died on 01/21/2008.
REFRACTORY ANAEMIA : Rituximab Side Effects Report #5472167-8
Physician from FRANCE reported RITUXIMAB problem on Sept 21, 2007. Female patient, weighting 154.3 lb, was diagnosed with b-cell lymphoma, prophylaxis, hypertension, osteoporosis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: refractory anaemia, . RITUXIMAB dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, ZECLAR, TRIFLUCAN, TENSTATEN, FOSAMAX. Patient recovered.
REFRACTORY ANAEMIA : Aranesp Side Effects Report #5377542-8
ARANESP problem was reported by a Pharmacist from CANADA on June 27, 2007. Female patient, weighting 284.4 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: refractory anaemia, . ARANESP dosage: unknown. During the same period patient was treated with MONOCOR, LASIX, CARDURA, DIOVAN, IMDUR, ASPIRIN, PLAVIX, PANTOPRAZOLE. Patient recovered.
REFRACTORY ANAEMIA : Aranesp Side Effects Report #5391191-7
Pharmacist from CANADA reported ARANESP problem on July 16, 2007. Female patient, weighting 284.4 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: refractory anaemia, . ARANESP dosage: unknown. During the same period patient was treated with MONOCOR, LASIX, CARDURA, DIOVAN, IMDUR, ASPIRIN, PLAVIX, PANTOPRAZOLE. Patient recovered.
REFRACTORY ANAEMIA : Aranesp Side Effects Report #5399019-6
ARANESP problem was reported by a Pharmacist from CANADA on July 23, 2007. Female patient, weighting 284.4 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: refractory anaemia, . ARANESP dosage: unknown. During the same period patient was treated with MONOCOR, LASIX, CARDURA, DIOVAN, IMDUR, ASPIRIN, PLAVIX, PANTOPRAZOLE. Patient recovered.
REFRACTORY ANAEMIA : Aranesp Side Effects Report #5377542-8
Pharmacist from CANADA reported ARANESP problem on June 27, 2007. Female patient, weighting 284.4 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: refractory anaemia, . ARANESP dosage: unknown. During the same period patient was treated with MONOCOR, LASIX, CARDURA, DIOVAN, IMDUR, ASPIRIN, PLAVIX, PANTOPRAZOLE. Patient recovered.
REFRACTORY ANAEMIA : Aranesp Side Effects Report #5391191-7
ARANESP problem was reported by a Pharmacist from CANADA on July 16, 2007. Female patient, weighting 284.4 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: refractory anaemia, . ARANESP dosage: unknown. During the same period patient was treated with MONOCOR, LASIX, CARDURA, DIOVAN, IMDUR, ASPIRIN, PLAVIX, PANTOPRAZOLE. Patient recovered.
REFRACTORY ANAEMIA : Aranesp Side Effects Report #5399019-6
Pharmacist from CANADA reported ARANESP problem on July 23, 2007. Female patient, weighting 284.4 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: refractory anaemia, . ARANESP dosage: unknown. During the same period patient was treated with MONOCOR, LASIX, CARDURA, DIOVAN, IMDUR, ASPIRIN, PLAVIX, PANTOPRAZOLE. Patient recovered.
REFRACTORY ANAEMIA : Plavix Side Effects Report #5675996-0
PLAVIX problem was reported by a Physician from FRANCE on Mar 12, 2008. Male patient was diagnosed with cardiovascular disorder and was treated with PLAVIX. After drug was administered, patient experienced the following problems/side effects: ill-defined disorder, refractory anaemia, . PLAVIX dosage: unknown. During the same period patient was treated with TAHOR. Patient was hospitalized. Patient died.
REFRACTORY ANAEMIA : Gemzar Side Effects Report #5608147-9
Physician from UNITED STATES reported GEMZAR problem on Jan 18, 2008. Male patient, 72 years of age, was diagnosed with lung adenocarcinoma stage iv and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: disease progression, refractory anaemia, spinal cord compression, . GEMZAR dosage: unknown. During the same period patient was treated with CARBOPLATIN, GEFITINIB. Patient died.
REFRACTORY ANAEMIA : Hydroxychloroqui Side Effects Report #5465429-1
HYDROXYCHLOROQUINE SULPHATE problem was reported by a Health Professional from UNITED STATES on Sept 11, 2007. Male patient, 76 years of age, was diagnosed with rheumatoid arthritis and was treated with HYDROXYCHLOROQUINE SULPHATE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, refractory anaemia, . HYDROXYCHLOROQUINE SULPHATE dosage: 400 MG, DAILY X 16 YEARS, ORAL. During the same period patient was treated with CARVEDILOL, SIMVASTATIN, FUROSEMIDE, ENALAPRIL MALEATE, AMITRIPTYLINE, IRON SULPHATETHIAMIN COMPOUND, PREDNISONE. Patient recovered.
REFRACTORY ANAEMIA : Hydroxychloroqui Side Effects Report #5465433-3
Health Professional from UNITED STATES reported HYDROXYCHLOROQUINE SULPHATE problem on Sept 11, 2007. Female patient, 65 years of age, was diagnosed with systemic lupus erythematosus and was treated with HYDROXYCHLOROQUINE SULPHATE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, refractory anaemia, . HYDROXYCHLOROQUINE SULPHATE dosage: 400 MG, DAILY X 13 YEARS, ORAL. During the same period patient was treated with INDOMETHACIN, ALENDRONATE, CALCIUM, LANSOPRAZOLE, DOCUSATE, DILTIAZEM. Patient recovered.
REFRACTORY ANAEMIA : Hydroxychloroqui Side Effects Report #5465439-4
HYDROXYCHLOROQUINE SULPHATE problem was reported by a Health Professional from UNITED STATES on Sept 11, 2007. Female patient, 71 years of age, was diagnosed with rheumatoid arthritis and was treated with HYDROXYCHLOROQUINE SULPHATE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, refractory anaemia, . HYDROXYCHLOROQUINE SULPHATE dosage: 400 MG, DAILY X 7 YEARS, ORAL. During the same period patient was treated with IBUPROFEN, ALENDRONATE, CALCIUM SUPPLEMENT, AMLODIPINE. Patient recovered.
REFRACTORY ANAEMIA : Hydroxychloroqui Side Effects Report #5465450-3
Health Professional from UNITED STATES reported HYDROXYCHLOROQUINE SULPHATE problem on Sept 11, 2007. Male patient, 65 years of age, was diagnosed with systemic lupus erythematosus and was treated with HYDROXYCHLOROQUINE SULPHATE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, refractory anaemia, . HYDROXYCHLOROQUINE SULPHATE dosage: 400 MG, DAILY X 6 YRS, ORAL. During the same period patient was treated with PREDNISONE, ASPIRIN, FLUOXETINE. Patient recovered.
REFRACTORY ANAEMIA : Hydroxychloroqui Side Effects Report #5420375-4
HYDROXYCHLOROQUINE SULPHATE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2007. Female patient, 65 years of age, was diagnosed with musculoskeletal pain and was treated with HYDROXYCHLOROQUINE SULPHATE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, refractory anaemia, . HYDROXYCHLOROQUINE SULPHATE dosage: (400 MG), ORAL. Patient recovered.
REFRACTORY ANAEMIA : Hydroxychloroqui Side Effects Report #5420376-6
Consumer or non-health professional from UNITED STATES reported HYDROXYCHLOROQUINE SULPHATE problem on Aug 01, 2007. Male patient, 76 years of age, was diagnosed with musculoskeletal disorder and was treated with HYDROXYCHLOROQUINE SULPHATE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, refractory anaemia, . HYDROXYCHLOROQUINE SULPHATE dosage: (400 MG), ORAL. Patient recovered.
REFRACTORY ANAEMIA : Procrit Side Effects Report #5392288-8
PROCRIT problem was reported by a Physician from UNITED STATES on July 12, 2007. Female patient was diagnosed with anaemia of malignant disease and was treated with PROCRIT. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell, refractory anaemia, . PROCRIT dosage: unknown. During the same period patient was treated with ISORDIL, SPIRIVA, COREG, INSULIN, HYDRALAZINE, MAGNESIUM OXIDE, DIGOXIN, NEURONTIN. Patient recovered.
REFRACTORY ANAEMIA : Procrit Side Effects Report #5392288-8
Physician from UNITED STATES reported PROCRIT problem on July 12, 2007. Female patient was diagnosed with anaemia of malignant disease and was treated with PROCRIT. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell, refractory anaemia, . PROCRIT dosage: unknown. During the same period patient was treated with ISORDIL, SPIRIVA, COREG, INSULIN, HYDRALAZINE, MAGNESIUM OXIDE, DIGOXIN, NEURONTIN. Patient recovered.
REFRACTORY ANAEMIA : Exjade Side Effects Report #5580245-8
EXJADE problem was reported by a Physician from UNITED STATES on Jan 02, 2008. Male patient, 65 years of age, was diagnosed with iron overload and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: disease progression, myelodysplastic syndrome, refractory anaemia, respiratory failure, sepsis, thrombocytopenia, . EXJADE dosage: 2000 MG, QD. Patient died on 10/15/2007.
REFRACTORY ANAEMIA : Carboplatin Side Effects Report #5603906-0
Physician from UNITED STATES reported CARBOPLATIN problem on Jan 15, 2008. Male patient, 72 years of age, was diagnosed with lung adenocarcinoma stage iv and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, refractory anaemia, spinal cord compression, therapeutic response decreased, . CARBOPLATIN dosage: unknown. During the same period patient was treated with GEFITINIB, GEMCITABINE, STEROIDS, OPIATES. Patient recovered.
REFRACTORY ANAEMIA : Thalomid Side Effects Report #5502850-7
THALOMID problem was reported by a Physician from UNITED STATES on Oct 23, 2007. Male patient, 76 years of age, was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, myelodysplastic syndrome, refractory anaemia, . THALOMID dosage: 200 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DECADRON. Patient died on 09/29/2007.
REFRACTORY ANAEMIA : Cyclophosphamide Side Effects Report #5400582-7
Health Professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on July 24, 2007. Male patient, 55 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome, refractory anaemia, . CYCLOPHOSPHAMIDE dosage: unknown. Patient recovered.
REFRACTORY ANAEMIA : Cyclophosphamide Side Effects Report #5400582-7
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED STATES on July 24, 2007. Male patient, 55 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome, refractory anaemia, . CYCLOPHOSPHAMIDE dosage: unknown. Patient recovered.